The University of Chicago Header Logo

Connection

Nancy Jean Cox to Influenza, Human

Back to Details
This is a "connection" page, showing publications Nancy Jean Cox has written about Influenza, Human.
Nancy Jean Cox
Connection Strength
11.725
Influenza, Human
  1. Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected. Lancet. 2022 09 24; 400(10357):981-982.
    View in: PubMed
    Score: 0.703
  2. A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014. BMC Public Health. 2019 May 10; 19(Suppl 3):520.
    View in: PubMed
    Score: 0.556
  3. 65 years of influenza surveillance by a World Health Organization-coordinated global network. Influenza Other Respir Viruses. 2018 09; 12(5):558-565.
    View in: PubMed
    Score: 0.524
  4. Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness. mBio. 2014 Dec 12; 5(6).
    View in: PubMed
    Score: 0.410
  5. H7N9: preparing for the unexpected in influenza. Annu Rev Med. 2015; 66:361-71.
    View in: PubMed
    Score: 0.406
  6. Influenza seasonality: timing and formulation of vaccines. Bull World Health Organ. 2014 May 01; 92(5):311.
    View in: PubMed
    Score: 0.393
  7. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). Curr Top Microbiol Immunol. 2014; 385:119-36.
    View in: PubMed
    Score: 0.384
  8. Alexander (Sasha) I. Klimov, PhD, ScD (1943-2013). Influenza Other Respir Viruses. 2013 May; 7(3):356-7.
    View in: PubMed
    Score: 0.366
  9. Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med. 2013 May 16; 368(20):1862-4.
    View in: PubMed
    Score: 0.365
  10. Influenza A(H1N1)pdm09 virus among healthy show pigs, United States. Emerg Infect Dis. 2012 Sep; 18(9):1519-21.
    View in: PubMed
    Score: 0.350
  11. Exposure science for viral diseases: 2009 H1N1 pandemic influenza virus. J Expo Sci Environ Epidemiol. 2011 Jan-Feb; 21(1):1-2.
    View in: PubMed
    Score: 0.310
  12. Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses. 2009 Mar; 3(2):51-8.
    View in: PubMed
    Score: 0.275
  13. Inactivated and live attenuated influenza vaccines in young children--how do they compare? N Engl J Med. 2007 Feb 15; 356(7):729-31.
    View in: PubMed
    Score: 0.238
  14. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10748-52.
    View in: PubMed
    Score: 0.174
  15. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000 Oct 04; 284(13):1677-82.
    View in: PubMed
    Score: 0.153
  16. Prevention and control of influenza. Lancet. 1999 Dec; 354 Suppl:SIV30.
    View in: PubMed
    Score: 0.145
  17. Influenza. Lancet. 1999 Oct 09; 354(9186):1277-82.
    View in: PubMed
    Score: 0.143
  18. Impact of epidemic influenza A-like acute respiratory illness in a remote jungle highland population in Irian Jaya, Indonesia. Clin Infect Dis. 1998 Apr; 26(4):880-8.
    View in: PubMed
    Score: 0.129
  19. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 1998 Jan 16; 279(5349):393-6.
    View in: PubMed
    Score: 0.127
  20. Influenza pandemic preparedness plan for the United States. J Infect Dis. 1997 Aug; 176 Suppl 1:S4-7.
    View in: PubMed
    Score: 0.123
  21. Panel summary of international pandemic influenza plans. J Infect Dis. 1997 Aug; 176 Suppl 1:S87-8.
    View in: PubMed
    Score: 0.123
  22. Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015. Vaccine. 2017 02 22; 35(8):1104-1109.
    View in: PubMed
    Score: 0.119
  23. Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol. 2016 05 23; 1(6):16058.
    View in: PubMed
    Score: 0.113
  24. [Vaccination against influenza in children with acute lymphoblastic leukemia]. Pediatr Pol. 1996 Apr; 71(4):301-6.
    View in: PubMed
    Score: 0.112
  25. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis. 1995 Nov; 172(5):1352-5.
    View in: PubMed
    Score: 0.109
  26. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Influenza Other Respir Viruses. 2015 Sep; 9(5):263-70.
    View in: PubMed
    Score: 0.108
  27. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015 Jul 09; 523(7559):217-20.
    View in: PubMed
    Score: 0.106
  28. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. Arch Intern Med. 1995 Mar 13; 155(5):533-7.
    View in: PubMed
    Score: 0.104
  29. Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Dec 12; 63(49):1151-4.
    View in: PubMed
    Score: 0.102
  30. Identification of molecular markers associated with alteration of receptor-binding specificity in a novel genotype of highly pathogenic avian influenza A(H5N1) viruses detected in Cambodia in 2013. J Virol. 2014 Dec; 88(23):13897-909.
    View in: PubMed
    Score: 0.101
  31. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015 Jan 15; 211(2):249-57.
    View in: PubMed
    Score: 0.100
  32. Genetic relatedness between influenza A (H1N1) viruses isolated from humans and pigs. J Gen Virol. 1994 Aug; 75 ( Pt 8):2103-7.
    View in: PubMed
    Score: 0.100
  33. Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep. 2014 Jun 06; 63(22):483-90.
    View in: PubMed
    Score: 0.099
  34. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine. 2014 Aug 20; 32(37):4713-25.
    View in: PubMed
    Score: 0.097
  35. Update: influenza activity - United States, September 29, 2013-February 8, 2014. MMWR Morb Mortal Wkly Rep. 2014 Feb 21; 63(7):148-54.
    View in: PubMed
    Score: 0.097
  36. Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins. J Virol. 2014 May; 88(9):4828-38.
    View in: PubMed
    Score: 0.097
  37. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993 Oct; 168(4):881-7.
    View in: PubMed
    Score: 0.094
  38. Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis. 2013 Dec; 57(12):1703-12.
    View in: PubMed
    Score: 0.094
  39. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis. 2013 Jul; 57 Suppl 1:S4-S11.
    View in: PubMed
    Score: 0.093
  40. Highly pathogenic avian influenza A(H7N3) virus in poultry workers, Mexico, 2012. Emerg Infect Dis. 2013; 19(9):1531-4.
    View in: PubMed
    Score: 0.090
  41. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012 Oct 05; 30(45):6461-71.
    View in: PubMed
    Score: 0.087
  42. Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein. J Biol Chem. 2012 Apr 27; 287(18):15109-17.
    View in: PubMed
    Score: 0.085
  43. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3944-9.
    View in: PubMed
    Score: 0.084
  44. Human influenza A (H1N2) viruses isolated from China. J Gen Virol. 1992 Feb; 73 ( Pt 2):383-7.
    View in: PubMed
    Score: 0.084
  45. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology. 2011 Apr 25; 413(1):139-47.
    View in: PubMed
    Score: 0.079
  46. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine. 2011 Feb 17; 29(9):1836-43.
    View in: PubMed
    Score: 0.078
  47. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis. 2011 Jan 01; 52 Suppl 1:S36-43.
    View in: PubMed
    Score: 0.078
  48. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010 Aug 06; 59(RR-8):1-62.
    View in: PubMed
    Score: 0.076
  49. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol. 2010 Aug; 84(16):8287-99.
    View in: PubMed
    Score: 0.075
  50. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
    View in: PubMed
    Score: 0.072
  51. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009 Nov 12; 361(20):1945-52.
    View in: PubMed
    Score: 0.071
  52. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31; 58(RR-8):1-52.
    View in: PubMed
    Score: 0.071
  53. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004. Arch Virol. 2009; 154(8):1249-61.
    View in: PubMed
    Score: 0.070
  54. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science. 2009 Jul 24; 325(5939):484-7.
    View in: PubMed
    Score: 0.070
  55. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009 Jul 10; 325(5937):197-201.
    View in: PubMed
    Score: 0.070
  56. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog. 2008 May 23; 4(5):e1000072.
    View in: PubMed
    Score: 0.065
  57. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008 Apr 18; 320(5874):340-6.
    View in: PubMed
    Score: 0.065
  58. Adamantane-resistant influenza infection during the 2004-05 season. Emerg Infect Dis. 2008 Jan; 14(1):173-6.
    View in: PubMed
    Score: 0.063
  59. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007 Jul 13; 56(RR-6):1-54.
    View in: PubMed
    Score: 0.061
  60. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science. 2007 Feb 02; 315(5812):655-9.
    View in: PubMed
    Score: 0.059
  61. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006 Nov 23; 355(21):2186-94.
    View in: PubMed
    Score: 0.059
  62. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006 Oct 15; 194(8):1032-9.
    View in: PubMed
    Score: 0.058
  63. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A. 2006 Aug 08; 103(32):12121-6.
    View in: PubMed
    Score: 0.057
  64. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 Jul 28; 55(RR-10):1-42.
    View in: PubMed
    Score: 0.057
  65. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine. 2006 Nov 17; 24(47-48):6859-66.
    View in: PubMed
    Score: 0.057
  66. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA. 2006 Feb 22; 295(8):891-4.
    View in: PubMed
    Score: 0.055
  67. The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet. 2006 Jan 07; 367(9504):84.
    View in: PubMed
    Score: 0.055
  68. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005 Dec 15; 353(24):2559-67.
    View in: PubMed
    Score: 0.055
  69. Family clustering of avian influenza A (H5N1). Emerg Infect Dis. 2005 Nov; 11(11):1799-1801.
    View in: PubMed
    Score: 0.054
  70. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005 Oct 07; 310(5745):77-80.
    View in: PubMed
    Score: 0.054
  71. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol. 2005 Sep; 79(18):11788-800.
    View in: PubMed
    Score: 0.054
  72. Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology. 2004 Oct 10; 328(1):101-19.
    View in: PubMed
    Score: 0.051
  73. Influenza-associated hospitalizations in the United States. JAMA. 2004 Sep 15; 292(11):1333-40.
    View in: PubMed
    Score: 0.050
  74. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004 May 28; 53(RR-6):1-40.
    View in: PubMed
    Score: 0.049
  75. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003 Apr 25; 52(RR-8):1-34; quiz CE1-4.
    View in: PubMed
    Score: 0.046
  76. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003 Jan 08; 289(2):179-86.
    View in: PubMed
    Score: 0.045
  77. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology. 2002 Nov 10; 303(1):1-8.
    View in: PubMed
    Score: 0.044
  78. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2002 Apr 12; 51(RR-3):1-31.
    View in: PubMed
    Score: 0.043
  79. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis. 2002 Apr 15; 185(8):1005-10.
    View in: PubMed
    Score: 0.042
  80. Molecular epidemiology of influenza A(H3N2) virus reinfections. J Infect Dis. 2002 Apr 01; 185(7):980-5.
    View in: PubMed
    Score: 0.042
  81. Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol. 2001 Jun; 82(Pt 6):1397-1406.
    View in: PubMed
    Score: 0.040
  82. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2001 Apr 20; 50(RR-4):1-44.
    View in: PubMed
    Score: 0.040
  83. Cruise ships: high-risk passengers and the global spread of new influenza viruses. Clin Infect Dis. 2000 Aug; 31(2):433-8.
    View in: PubMed
    Score: 0.038
  84. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A. 2000 Aug 15; 97(17):9654-8.
    View in: PubMed
    Score: 0.038
  85. Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol. 2000 Aug; 114(2):227-33.
    View in: PubMed
    Score: 0.038
  86. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000 Apr 14; 49(RR-3):1-38; quiz CE1-7.
    View in: PubMed
    Score: 0.037
  87. Influenza virus NS1- C/EBPß gene regulatory complex inhibits RIG-I transcription. Antiviral Res. 2020 04; 176:104747.
    View in: PubMed
    Score: 0.037
  88. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis. 2000 Jan; 181(1):344-8.
    View in: PubMed
    Score: 0.036
  89. Predicting the evolution of human influenza A. Science. 1999 Dec 03; 286(5446):1921-5.
    View in: PubMed
    Score: 0.036
  90. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis. 1999 Dec; 180(6):1763-70.
    View in: PubMed
    Score: 0.036
  91. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis. 1999 Sep-Oct; 5(5):659-71.
    View in: PubMed
    Score: 0.036
  92. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology. 1999 Aug 15; 261(1):15-9.
    View in: PubMed
    Score: 0.035
  93. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis. 1999 Aug; 180(2):505-8.
    View in: PubMed
    Score: 0.035
  94. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol. 1999 Jul; 73(7):5903-11.
    View in: PubMed
    Score: 0.035
  95. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology. 1999 Feb 01; 254(1):115-23.
    View in: PubMed
    Score: 0.034
  96. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol. 1998 Aug; 72(8):6678-88.
    View in: PubMed
    Score: 0.033
  97. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998 Jul; 178(1):53-60.
    View in: PubMed
    Score: 0.033
  98. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis. 1998 Jun; 26(6):1418-24.
    View in: PubMed
    Score: 0.033
  99. Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med. 1997 Feb; 162(2):82-6.
    View in: PubMed
    Score: 0.030
  100. Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins. Sci Rep. 2016 Jan 11; 6:19063.
    View in: PubMed
    Score: 0.028
  101. An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol. 1994 Apr; 68(4):2051-8.
    View in: PubMed
    Score: 0.024
  102. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol. 1993 Nov; 74 ( Pt 11):2513-8.
    View in: PubMed
    Score: 0.024
  103. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology. 2012 Jan 05; 422(1):105-13.
    View in: PubMed
    Score: 0.021
  104. Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One. 2011; 6(9):e25091.
    View in: PubMed
    Score: 0.020
  105. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 2011 Jun 15; 83(12):4729-37.
    View in: PubMed
    Score: 0.020
  106. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol. 1991 May; 65(5):2340-50.
    View in: PubMed
    Score: 0.020
  107. Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One. 2008; 3(10):e3462.
    View in: PubMed
    Score: 0.017
  108. Pathogenicity and antigenicity of a new influenza A (H5N1) virus isolated from duck meat. J Med Virol. 2003 Apr; 69(4):553-9.
    View in: PubMed
    Score: 0.011
  109. Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978. Infect Immun. 1980 Jun; 28(3):753-61.
    View in: PubMed
    Score: 0.009
  110. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999 Apr; 37(4):937-43.
    View in: PubMed
    Score: 0.009
  111. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis. 1999 Mar; 28(3):541-7.
    View in: PubMed
    Score: 0.009
  112. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. Virology. 1996 Oct 01; 224(1):175-83.
    View in: PubMed
    Score: 0.007
  113. Recombination of human influenza A viruses in nature. Nature. 1980 Apr 17; 284(5757):638-40.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.